User login
Acne and Rosacea: A Supplement to Dermatology News 2020
This Acne and Rosacea supplement to Dermatology News includes commentary from Dr Hilary E. Baldwin
Topics Included:
Pathogenic Pathway As Target In Rosacea Treatment / 5
Acne In Skin Of Color / 6
Under FDA Review Of Novel Acne Treatment / 7
Chemical Peels For Acne / 8
Isotretinoin And Psychiatric Conditions / 10
Pregnancy Reports For Isotretinoin / 11
Rosacea Triggers / 12
Topical Treatment Of Demodex / 13
Social Media And Acne / 14
This Acne and Rosacea supplement to Dermatology News includes commentary from Dr Hilary E. Baldwin
Topics Included:
Pathogenic Pathway As Target In Rosacea Treatment / 5
Acne In Skin Of Color / 6
Under FDA Review Of Novel Acne Treatment / 7
Chemical Peels For Acne / 8
Isotretinoin And Psychiatric Conditions / 10
Pregnancy Reports For Isotretinoin / 11
Rosacea Triggers / 12
Topical Treatment Of Demodex / 13
Social Media And Acne / 14
This Acne and Rosacea supplement to Dermatology News includes commentary from Dr Hilary E. Baldwin
Topics Included:
Pathogenic Pathway As Target In Rosacea Treatment / 5
Acne In Skin Of Color / 6
Under FDA Review Of Novel Acne Treatment / 7
Chemical Peels For Acne / 8
Isotretinoin And Psychiatric Conditions / 10
Pregnancy Reports For Isotretinoin / 11
Rosacea Triggers / 12
Topical Treatment Of Demodex / 13
Social Media And Acne / 14
The CGRP Receptor: What Neurologists Need to Know
Click here to read the content.
USA-334-84065
Click here to read the content.
USA-334-84065
Click here to read the content.
USA-334-84065
Assessing Spinal Muscular Atrophy Across the Patient Journey
Click here to read.
Supplement Faculty
Perry Shieh, MD, PhD
Professor
Department of Neurology
David Geffen School
of Medicine at UCLA
Ronald Reagan UCLA
Medical Center
Los Angeles, CA
Sally Dunaway Young, PT, DPT
Physical Therapist
and Clinical Research
Evaluator/Manager
Stanford University School
of Medicine
Stanford, CA
Click here to read.
Supplement Faculty
Perry Shieh, MD, PhD
Professor
Department of Neurology
David Geffen School
of Medicine at UCLA
Ronald Reagan UCLA
Medical Center
Los Angeles, CA
Sally Dunaway Young, PT, DPT
Physical Therapist
and Clinical Research
Evaluator/Manager
Stanford University School
of Medicine
Stanford, CA
Click here to read.
Supplement Faculty
Perry Shieh, MD, PhD
Professor
Department of Neurology
David Geffen School
of Medicine at UCLA
Ronald Reagan UCLA
Medical Center
Los Angeles, CA
Sally Dunaway Young, PT, DPT
Physical Therapist
and Clinical Research
Evaluator/Manager
Stanford University School
of Medicine
Stanford, CA
State of Practice: Management Practice for Thromboprophylaxis in Acutely Ill Medical Patients
In this issue of CHEST Clinical Perspectives, CHEST is undertaking primary research with pulmonologists and intensivists to understand their approach to ordering thromboprophylaxis in acutely ill medical patients for the purpose of reducing risk of VTE. Specifically, this issue focuses on the extent to which management practice has evolved given the introduction of novel anticoagulants. The objectives of this research are to:
- Understand current practice related to ordering thromboprophylaxis, as well as the therapies used with acutely ill medical patients.
- Understand the attitudes toward thromboprophylaxis from a risk and benefit standpoint that underlie decision-making related to deployment of therapy.
- Assess therapeutic, clinical, and administrative factors that impact management choices and the adoption of novel anticoagulants.
- Assess familiarity with and influence of the MAGELLAN study.
- Identify differences in management based on practice tenure and setting (academic vs community-based).
In this issue of CHEST Clinical Perspectives, CHEST is undertaking primary research with pulmonologists and intensivists to understand their approach to ordering thromboprophylaxis in acutely ill medical patients for the purpose of reducing risk of VTE. Specifically, this issue focuses on the extent to which management practice has evolved given the introduction of novel anticoagulants. The objectives of this research are to:
- Understand current practice related to ordering thromboprophylaxis, as well as the therapies used with acutely ill medical patients.
- Understand the attitudes toward thromboprophylaxis from a risk and benefit standpoint that underlie decision-making related to deployment of therapy.
- Assess therapeutic, clinical, and administrative factors that impact management choices and the adoption of novel anticoagulants.
- Assess familiarity with and influence of the MAGELLAN study.
- Identify differences in management based on practice tenure and setting (academic vs community-based).
In this issue of CHEST Clinical Perspectives, CHEST is undertaking primary research with pulmonologists and intensivists to understand their approach to ordering thromboprophylaxis in acutely ill medical patients for the purpose of reducing risk of VTE. Specifically, this issue focuses on the extent to which management practice has evolved given the introduction of novel anticoagulants. The objectives of this research are to:
- Understand current practice related to ordering thromboprophylaxis, as well as the therapies used with acutely ill medical patients.
- Understand the attitudes toward thromboprophylaxis from a risk and benefit standpoint that underlie decision-making related to deployment of therapy.
- Assess therapeutic, clinical, and administrative factors that impact management choices and the adoption of novel anticoagulants.
- Assess familiarity with and influence of the MAGELLAN study.
- Identify differences in management based on practice tenure and setting (academic vs community-based).
Pediatric Dermatology: A Supplement to Pediatric News & Dermatology News
Content includes:
- Early onset of atopic dermatitis linked to poorer control, could signify more persistent disease
- Patients with actopic dermatitis should be routinely asked about conjunctivitis
- Hope on the horizon: New cantharidin formulation alleviates molluscum contagiosum in pivotal trials
- Patch testing in atopic dermatitis: When and how
- Topical calcineurin inhibitors are an effective treatment option for periorificial dermatitis
- Psychology consults for children’s skin issues can boost adherence, wellness
Content includes:
- Early onset of atopic dermatitis linked to poorer control, could signify more persistent disease
- Patients with actopic dermatitis should be routinely asked about conjunctivitis
- Hope on the horizon: New cantharidin formulation alleviates molluscum contagiosum in pivotal trials
- Patch testing in atopic dermatitis: When and how
- Topical calcineurin inhibitors are an effective treatment option for periorificial dermatitis
- Psychology consults for children’s skin issues can boost adherence, wellness
Content includes:
- Early onset of atopic dermatitis linked to poorer control, could signify more persistent disease
- Patients with actopic dermatitis should be routinely asked about conjunctivitis
- Hope on the horizon: New cantharidin formulation alleviates molluscum contagiosum in pivotal trials
- Patch testing in atopic dermatitis: When and how
- Topical calcineurin inhibitors are an effective treatment option for periorificial dermatitis
- Psychology consults for children’s skin issues can boost adherence, wellness